Current Position: Research Fellow at the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, USA
Arash Etemadi has an M.D. M.P.H., and Ph.D. in epidemiology from Tehran University of Medical Sciences (TUMS), Iran. As a result of Dr. Etemadi's interest in genetic epidemiology, he worked on familial aggregation of myopia and segregation analysis of refractive errors. Dr. Etemadi did a postdoctoral fellowship at the University of Maastricht in the Netherlands, working on polymorphisms in the genes responsible for the metabolism of polycyclic aromatic hydrocarbons (PAHs) and DNA repair in relation to esophageal cancer. He was appointed as an Assistant Professor of Epidemiology at Tehran University of Medical Sciences. He joined NIH as a visiting fellow in June 2010, and was promoted to Research Fellow in June 2015.
The main focus of his research is population-based studies on the molecular basis for early detection and prevention of chronic diseases, including cancer, and he is studying the exposure to PAHs from tobacco and non-tobacco sources in a number of studies and research collaborations. He is also interested in obesity, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). In 2012, Dr. Etemadi received an Intramural Research Award to assess molecular markers of carcinogenic exposure in the esophagus, and in 2013 the NCI Director’s Innovation Award to study the role of cancer stem cells in esophageal cancer. He has also received the Fellows’ Award for Research Excellence (2012), and Fellowship Achievement Award (2013). In 2015, he was selected as a finalist in the NIH Earl Stadtman Investigator Search. He is also an Adjunct Faculty at the Digestive Disease Research Institute, Tehran University of Medical Sciences.